Endothelial cell-derived MMP14 in lung alveolar regeneration and fibrosis
内皮细胞衍生的 MMP14 在肺泡再生和纤维化中的作用
基本信息
- 批准号:10022328
- 负责人:
- 金额:$ 48.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AlveolarAntibodiesBleomycinBlood CirculationBlood PlateletsBlood VesselsCapillary Endothelial CellCause of DeathCaveolaeCell physiologyCell surfaceCellsCicatrixClinicalCuesDTR geneDataDepositionDisabled PersonsEGF geneEndothelial CellsEndotheliumEpidermal Growth Factor ReceptorEpithelialEpithelial CellsEpitheliumExcisionExtracellular MatrixFibroblast Growth Factor Receptor 1FibrosisHeparin BindingImpairmentInfusion proceduresInjectionsLeftLungLung CapacityLung TransplantationLung diseasesMMP14 geneMediatingMembraneMetalloproteasesModelingMusNatural regenerationOrganOutcomeOutcome StudyPECAM1 genePharmacotherapyPilot ProjectsPneumonectomyProcessProteolysisPulmonary FibrosisRegulationRespiratory physiologySignal TransductionStructure of parenchyma of lungSystemTestingTherapeuticTherapeutic EffectTransduction GeneVascular Endothelial CellViralVirusWeightalveolar epitheliumcyr61 proteindesignend stage diseaseepithelial stem cellepithelium regenerationexperimental studyinjuredlung injurylung lobelung regenerationlung repairmortalitymouse modelnovel therapeutic interventionpreventpublic health relevanceregenerativeregenerative therapyrepairedrestorationstemstem cell proliferationstem cellstherapeutic evaluation
项目摘要
DESCRIPTION (provided by applicant): Lung diseases are the leading cause of mortality in the U.S. Current therapy mainly relies on short-term pharmacotherapy and lung transplantation with limited sustained clinical benefit. Stimulating propagation of alveolar epithelial cells (AECs could increase the lung's capacity to undergo self-repair. Nevertheless, AEC expansion in a diseased lung is frequently handicapped by the lack of epithelially-active cues from the dysfunctional surrounding microenvironmental/niche cells. Consequently, impaired lung repair often provokes excessive scar formation and fibrosis that might inhibit epithelial expansion. We have shown that surgical removal of left lung lobe (pneumonectomy) in mice causes compensatory re-alveolarization in the right lungs. This alveolar regeneration is stimulated by platelets and pulmonary capillary endothelial cells (PCECs). Following pneumonectomy (PNX), platelets deposited in the right lungs upregulate membrane-type metalloproteinase MMP14 in PCECs to stimulate the proliferation of alveolar epithelial stem/progenitor cells such as type 2 AECs (AEC2s). Thus, platelets upregulate epithelially active MMP14 in PCECs to elicit alveolar regeneration. Since this "hemo-vascular niche" is readily accessible to the circulation, it represents an attractive target to enable therapeutic lung repair. Endothelial MMP14 stimulates AEC expansion by releasing the ectodomain of transmembrane heparin-binding EGF (HB-EGF) that activates EGF receptor (EGFR). Pilot data suggest that MMP14 localized in endothelial cell caveolae blocks lung fibrosis via liberating anti-fibrotic molecule cysteine-rich protein 61 (Cyr61 from extracellular matrix. Caveolar enrichment of MMP14 is induced by platelet-mediated fibroblast growth factor receptor 1 (FGFR1) activation in PCECs. Thus, we hypothesize that MMP14 in the endothelial cell caveolae promotes lung regeneration and blocks fibrosis. To test this hypothesis, we will use mouse pneumonectomy and lung fibrosis model induced by repeated intratracheal injection of Bleomycin to 1) define how endothelial MMP14 processes HB-EGF and Cyr61 to regulate lung regeneration and fibrosis; 2) investigate FGFR1-dependent regulation of MMP14 function. Moreover, we also aim to combine PCEC-targeted gene transduction system and platelet infusion to direct MMP14 in the caveolae of PCECs to promote lung regeneration and prevent fibrosis. This study will help to elucidate how microenvironmental cues such as endothelial MMP14 modulate lung regeneration and fibrosis. Positive outcome of the proposed experiments will help to design a "niche-targeted" regenerative therapy to facilitate functional lung repair without fibrosis.
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Role of endothelial cells in tumor microenvironment.
- DOI:10.1002/ctm2.450
- 发表时间:2021-06
- 期刊:
- 影响因子:10.6
- 作者:Yang D;Guo P;He T;Powell CA
- 通讯作者:Powell CA
Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease.
- DOI:10.3390/jcm10102188
- 发表时间:2021-05-19
- 期刊:
- 影响因子:3.9
- 作者:Ng N;Powell CA
- 通讯作者:Powell CA
Vascular Notch Signaling in Stress Hematopoiesis.
- DOI:10.3389/fcell.2020.606448
- 发表时间:2020
- 期刊:
- 影响因子:5.5
- 作者:Huang C;Yang D;Ye GW;Powell CA;Guo P
- 通讯作者:Guo P
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles A. Powell其他文献
Cell–cell communication: old mystery and new opportunity
- DOI:
10.1007/s10565-019-09470-y - 发表时间:
2019-02-27 - 期刊:
- 影响因子:5.900
- 作者:
Dongli Song;Dawei Yang;Charles A. Powell;Xiangdong Wang - 通讯作者:
Xiangdong Wang
Schoolwide Impact and AVID: How Have Selected Texas High Schools Addressed the New Accountability Measures?
全校影响和 AVID:德克萨斯州部分高中如何应对新的问责措施?
- DOI:
10.1207/s15327671espr1101_4 - 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
K. Watt;Charles A. Powell;Irma Doris Mendiola;Griselda Cossio - 通讯作者:
Griselda Cossio
Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer
- DOI:
10.1007/s10549-020-05754-8 - 发表时间:
2020-06-26 - 期刊:
- 影响因子:3.000
- 作者:
Michelle D. Hackshaw;Heather E. Danysh;Jasmeet Singh;Mary E. Ritchey;Amy Ladner;Corina Taitt;D. Ross Camidge;Hiroji Iwata;Charles A. Powell - 通讯作者:
Charles A. Powell
Characterization and Antibacterial Activity of Oil-In-Water Nano-Emulsion Formulation Against Candidatus Liberibacter asiaticus.
水包油纳米乳液制剂对亚洲自由杆菌的表征和抗菌活性。
- DOI:
10.1094/pdis-05-16-0600-re - 发表时间:
2016 - 期刊:
- 影响因子:4.5
- 作者:
C. Y. Yang;Charles A. Powell;Yongping Duan;Muqing Zhang - 通讯作者:
Muqing Zhang
Novel paradigms of macrophage biology and function: identification of disease biomarkers and therapeutic targets
- DOI:
10.1007/s10565-022-09749-7 - 发表时间:
2022-07-18 - 期刊:
- 影响因子:5.900
- 作者:
Diane Catherine Wang;Xuanqi Liu;Charles A. Powell;Xiangdong Wang - 通讯作者:
Xiangdong Wang
Charles A. Powell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles A. Powell', 18)}}的其他基金
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
8319725 - 财政年份:2007
- 资助金额:
$ 48.88万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7738519 - 财政年份:2007
- 资助金额:
$ 48.88万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7213198 - 财政年份:2007
- 资助金额:
$ 48.88万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
8004958 - 财政年份:2007
- 资助金额:
$ 48.88万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7334742 - 财政年份:2007
- 资助金额:
$ 48.88万 - 项目类别:
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
腺癌侵袭中的肺上皮-间质相互作用
- 批准号:
7538365 - 财政年份:2007
- 资助金额:
$ 48.88万 - 项目类别:
MOLECULAR ALTERATIONS IN EPITHELIAL CELLS OF SMOKERS
吸烟者上皮细胞的分子变化
- 批准号:
6567819 - 财政年份:2001
- 资助金额:
$ 48.88万 - 项目类别:
MOLECULAR ALTERATIONS IN EPITHELIAL CELLS OF SMOKERS
吸烟者上皮细胞的分子变化
- 批准号:
6468557 - 财政年份:2000
- 资助金额:
$ 48.88万 - 项目类别:
SUSCEPTIBILITY TO MOLECULAR ALTERATION: EPITHELIAL CELLS
对分子改变的敏感性:上皮细胞
- 批准号:
6524698 - 财政年份:1999
- 资助金额:
$ 48.88万 - 项目类别:
SUSCEPTIBILITY TO MOLECULAR ALTERATION--EPITHELIAL CELLS
对分子改变的敏感性——上皮细胞
- 批准号:
6031932 - 财政年份:1999
- 资助金额:
$ 48.88万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 48.88万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 48.88万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 48.88万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 48.88万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 48.88万 - 项目类别:














{{item.name}}会员




